{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T08:07:10Z","timestamp":1780042030630,"version":"3.53.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100012331","name":"Agentschap Innoveren en Ondernemen","doi-asserted-by":"publisher","award":["HBC.2020.2697"],"award-info":[{"award-number":["HBC.2020.2697"]}],"id":[{"id":"10.13039\/100012331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00216-026-06485-3","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T02:30:27Z","timestamp":1778121027000},"page":"3791-3806","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A sensitive LC\u2011MS\/MS method for the simultaneous quantification of hexosylceramides and hexosylsphingosines, their precursors and metabolites in cells, plasma, and tissue homogenates"],"prefix":"10.1007","volume":"418","author":[{"given":"Michele","family":"Iannone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine","family":"Loomans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Gorremans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elien","family":"Grajchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Deneubourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Hrupka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Ver Donck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Bretteville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diederik","family":"Moechars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob J.","family":"Vreeken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Jahouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"6485_CR1","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1007\/s00018-007-7076-0","volume":"64","author":"S Lahiri","year":"2007","unstructured":"Lahiri S, Futerman AH. The metabolism and function of sphingolipids and glycosphingolipids. Cell Mol Life Sci. 2007;64:2270\u201384.","journal-title":"Cell Mol Life Sci"},{"key":"6485_CR2","doi-asserted-by":"publisher","first-page":"6338","DOI":"10.1111\/febs.12559","volume":"280","author":"G D\u2019Angelo","year":"2013","unstructured":"D\u2019Angelo G, Capasso S, Sticco L, Russo D. Glycosphingolipids: synthesis and functions. FEBS J. 2013;280:6338\u201353.","journal-title":"FEBS J"},{"key":"6485_CR3","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cmet.2021.06.006","volume":"33","author":"CD Green","year":"2021","unstructured":"Green CD, Maceyka M, Cowart LA, Spiegel S. Sphingolipids in metabolic disease: the good, the bad, and the unknown. Cell Metab. 2021;33:1293\u2013306.","journal-title":"Cell Metab"},{"key":"6485_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2025.106851","volume":"207","author":"AJ Hulsmeier","year":"2025","unstructured":"Hulsmeier AJ. Glycosphingolipids in neurodegeneration \u2013 molecular mechanisms, cellular roles, and therapeutic perspectives. Neurobiol Dis. 2025;207:1\u201316.","journal-title":"Neurobiol Dis"},{"key":"6485_CR5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/978-94-007-5416-4_16","volume":"65","author":"TR Mhyre","year":"2012","unstructured":"Mhyre TR, Boyd JT, Hamill RW, Maguire-Zeiss KA. Parkinson\u2019s disease. Subcell Biochem. 2012;65:389\u2013455.","journal-title":"Subcell Biochem"},{"key":"6485_CR6","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet. 2015;386:896\u2013912.","journal-title":"Lancet"},{"key":"6485_CR7","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA. 2020;323:548\u201360.","journal-title":"JAMA"},{"key":"6485_CR8","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397:2284\u2013303.","journal-title":"Lancet"},{"key":"6485_CR9","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1002\/mds.26802","volume":"31","author":"YC Wong","year":"2016","unstructured":"Wong YC, Krainc D. Lysosomal trafficking defects link Parkinson\u2019s disease with Gaucher\u2019s disease. Mov Disord. 2016;31:1610\u20138.","journal-title":"Mov Disord"},{"key":"6485_CR10","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1002\/jnr.23751","volume":"94","author":"MS Marshall","year":"2016","unstructured":"Marshall MS, Bongarzone ER. Beyond Krabbe\u2019s disease: the potential contribution of galactosylceramidase deficiency to neuronal vulnerability in late-onset synucleinopathies. J Neurosci Res. 2016;94:1328\u201332.","journal-title":"J Neurosci Res"},{"key":"6485_CR11","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1093\/glycob\/cwab046","volume":"31","author":"S Reza","year":"2021","unstructured":"Reza S, Ugorski M, Suchanski J. Glucosylceramide and galactosylceramide, small glycosphingolipids with significant impact on health and disease. Glycobiology. 2021;31:1416\u201334.","journal-title":"Glycobiology"},{"key":"6485_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0073094","volume":"8","author":"MM Mielke","year":"2013","unstructured":"Mielke MM, Maetzler W, Haughey NJ, Bandaru VVR, Savica R, Deuschle C, et al. Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson\u2019s disease and associated with cognitive impairment: a pilot study. PLoS One. 2013;8:1\u20136.","journal-title":"PLoS One"},{"key":"6485_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/acn3.177","volume":"2","author":"EM Rocha","year":"2015","unstructured":"Rocha EM, Smith GA, Park E, Cao H, Brown E, Hallett P, et al. Progressive decline of glucocerebrosidase in aging and Parkinson\u2019s disease. Ann Clin Transl Neurol. 2015;2:433\u20138.","journal-title":"Ann Clin Transl Neurol"},{"key":"6485_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.cbpa.2019.10.006","volume":"53","author":"JMFG Aerts","year":"2019","unstructured":"Aerts JMFG, Kuo CL, Lelieveld LT, Boer DEC, van der Lienden MJC, Overkleeft HS, et al. Glycosphingolipids and lysosomal storage disorders as illustrated by Gaucher disease. Curr Opin Chem Biol. 2019;53:204\u201315.","journal-title":"Curr Opin Chem Biol"},{"key":"6485_CR15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/WCO.0000000000000715","volume":"32","author":"E Ryan","year":"2019","unstructured":"Ryan E, Seehra G, Sharma P, Sidransky E. GBA1-associated parkinsonism: new insights and therapeutic opportunities. Curr Opin Neurol. 2019;32:589\u201396.","journal-title":"Curr Opin Neurol"},{"key":"6485_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-020-02145-7","author":"S Martin","year":"2020","unstructured":"Martin S, Smolders S, Haute CVD, Heeman B, Veen SV. Mutated ATP10B increases Parkinson \u2019 s disease risk by compromising lysosomal glucosylceramide export. Acta Neuropathol. 2020. https:\/\/doi.org\/10.1007\/s00401-020-02145-7.","journal-title":"Acta Neuropathol"},{"key":"6485_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yclnex.2018.05.001","volume":"20","author":"A Shamim","year":"2018","unstructured":"Shamim A, Mahmood T, Ahsan F, Kumar A, Bagga P. Lipids: an insight into the neurodegenerative disorders. Clin Nutr Exp. 2018;20:1\u201319.","journal-title":"Clin Nutr Exp"},{"key":"6485_CR18","first-page":"576","volume":"504","author":"HC Lee","year":"2018","unstructured":"Lee HC, Yokomizo T. Applications of mass spectrometry-based targeted and non-targeted lipidomics. BBRC. 2018;504:576\u201381.","journal-title":"BBRC"},{"key":"6485_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10337-018-3656-4","volume":"82","author":"M Lange","year":"2019","unstructured":"Lange M, Ni Z, Criscuolo A, Fedorova M. Liquid chromatography techniques in lipidomics research. Chromatographia. 2019;82:77\u2013100.","journal-title":"Chromatographia"},{"key":"6485_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms25042249","volume":"25","author":"I Gerhardtova","year":"2024","unstructured":"Gerhardtova I, Jankech T, Majerova P, Piestansky J, Olesova D, Kovac A, et al. Recent analytical methodologies in lipid analysis. Int J Mol Sci. 2024;25:1\u201329.","journal-title":"Int J Mol Sci"},{"key":"6485_CR21","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1021\/acs.analchem.5b04227","volume":"88","author":"M Boutin","year":"2016","unstructured":"Boutin M, Sun Y, Shack JJ, Auray-Blais C. Tandem mass spectrometry multiplex analysis of glucosylceramide and galactosylceramide isoforms in brain tissues at different stage of Parkinson disease. Anal Chem. 2016;88:1856\u201363.","journal-title":"Anal Chem"},{"key":"6485_CR22","doi-asserted-by":"publisher","first-page":"12875","DOI":"10.1021\/acs.analchem.4c02654","volume":"96","author":"L Castillo-Ribelles","year":"2024","unstructured":"Castillo-Ribelles L, Arranz-Amo JA, Hernandez-Vara J, Samaniego-Toro D, Enriquez-Calzada S, Lucas-Del Pozo S, et al. Evaluation of a liquid chromatography \u2013 tandem mass spectrometry method for the analysis of glucosylceramide and galactosylceramide isoforms in cerebrospinal fluid of Parkinson\u2019s disease patients. Anal Chem. 2024;96:12875\u201382.","journal-title":"Anal Chem"},{"key":"6485_CR23","doi-asserted-by":"publisher","first-page":"8288","DOI":"10.1021\/acs.analchem.7b01442","volume":"89","author":"R Hamler","year":"2017","unstructured":"Hamler R, Brignol N, Clark SW, Morrison S, Dungan LB, Chang HH, et al. Glucosylceramide and glucosylsphingosine quantitation by liquid chromatography-tandem mass spectrometry to enable in vivo preclinical studies on neuronopathic Gaucher disease. Anal Chem. 2017;89:8288\u201395.","journal-title":"Anal Chem"},{"key":"6485_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41531-021-00241-3","volume":"7","author":"YE Huh","year":"2021","unstructured":"Huh YE, Park H, Chiang MSR, Tuncali I, Liu G, Locascio JJ, et al. Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson\u2019s disease enrolled in PPMI. Npj Parkinson\u2019s Dis. 2021;7:102\u20138.","journal-title":"Npj Parkinson\u2019s Dis"},{"key":"6485_CR25","doi-asserted-by":"crossref","unstructured":"Irun P, Cebolla JJ, Lopez de Frutos L, De Castro-Oros I, Roca-Espiau M, Giraldo P. LC-MS\/MS analysis of plasma glucosylsphingosine as a biomarker for diagnosis and follow-up monitoring in Gaucher disease in the Spanish population. Clin Chem Lab Med. 2020;aop: 1\u201312.","DOI":"10.1515\/cclm-2019-0949"},{"key":"6485_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.clinbiochem.2020.10.011","volume":"87","author":"C Tang","year":"2021","unstructured":"Tang C, Jia X, Tang F, Liu S, Jiang X, Zhao X, et al. Detection of glucosylsphingosine in dried blood spots for diagnosis of Gaucher disease by LC-MS\/MS. Clin Biochem. 2021;87:79\u201384.","journal-title":"Clin Biochem"},{"key":"6485_CR27","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1007\/s00216-021-03853-z","volume":"414","author":"Y Xu","year":"2022","unstructured":"Xu Y, Li H, Han Y, Wang T, Wang Y, Gong J, et al. A simple and rapid method for extraction and measurement of circulating sphingolipids using LC\u2013MS\/MS: a targeted lipidomic analysis. Anal Bioanal Chem. 2022;414:2041\u201354.","journal-title":"Anal Bioanal Chem"},{"key":"6485_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpba.2022.114852","volume":"217","author":"S Matsumoto","year":"2022","unstructured":"Matsumoto S, Sato S, Otake K, Kosugi Y. Highly-sensitive simultaneous quantitation of glucosylsphingosine and galactosylsphingosine in human cerebrospinal fluid by liquid chromatography\/tandem mass spectrometry. J Pharm Biomed Anal. 2022;217:1\u20137.","journal-title":"J Pharm Biomed Anal"},{"key":"6485_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.dmpk.2023.100530","volume":"53","author":"S Sato","year":"2023","unstructured":"Sato S, Matsumoto S, Kosugi Y. Quantitation and characterization of glucosylsphingosine in cerebrospinal fluid (CSF), plasma, and brain of monkey model with Gaucher disease. DMPK. 2023;53:1\u20136.","journal-title":"DMPK"},{"key":"6485_CR30","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1194\/jlr.D005322","volume":"51","author":"M Scherer","year":"2010","unstructured":"Scherer M, Leuth\u00e4user-Jaschinski K, Ecker J, Schmitz G, Liebish G. A rapid and quantitative LC-MS\/MS method to profile sphingolipids. J Lipid Res. 2010;51:2001\u201311.","journal-title":"J Lipid Res"},{"key":"6485_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/bmc.4235","volume":"32","author":"R Sidhu","year":"2018","unstructured":"Sidhu R, Mikulka CR, Fujiwara H, Sands MS, Schaffer JE, Ory DS, et al. A HILIC method for simultaneous quantification of the lysosomal disease markers galactosylsphingosine and glucosylsphingosine in mouse serum. Biomed Chromatogr. 2018;32:1\u201320.","journal-title":"Biomed Chromatogr"},{"key":"6485_CR32","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1021\/acs.analchem.0c04542","volume":"93","author":"LS Bailey","year":"2021","unstructured":"Bailey LS, Huang F, Gao T, Zhao J, Basso KB, Guo Z. Characterization of glycosphingolipids and their diverse lipid forms through two-stage matching of LC-MS\/MS spectra. Anal Chem. 2021;93:3154\u201362.","journal-title":"Anal Chem"},{"key":"6485_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms222413643","volume":"22","author":"RK Saini","year":"2021","unstructured":"Saini RK, Prasad P, Shang X, Keum YS. Advances in lipid extraction methods \u2013 a review. Int J Mol Sci. 2021;22:1\u201319.","journal-title":"Int J Mol Sci"},{"key":"6485_CR34","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration (FDA) Q2(R2) Validation of Analytical Procedures. Guidance for Industry. 2024;1\u201336 (last access 21\/04\/2026)."},{"key":"6485_CR35","unstructured":"European Medicines Agency (EMA) ICH Q2(R2) Guideline on validation of analytical procedures. 2024;1-33 (last access 21\/04\/2026)."},{"key":"6485_CR36","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jpba.2016.06.017","volume":"128","author":"R Thakare","year":"2016","unstructured":"Thakare R, Chhonker YS, Gautam N, Alamoudi JA. Quantitative analysis of endogenous compounds. J Pharm Biomed Anal. 2016;128:426\u201337.","journal-title":"J Pharm Biomed Anal"},{"key":"6485_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpba.2026.117392","volume":"274","author":"M Iannone","year":"2026","unstructured":"Iannone M, Vereyken L, Grajchen E, Deneubourg C, Gorremans S, Ver Donck L, et al. Development and validation of a robust UPLC-MS\/MS method for the analysis of polyamines in cells, biofluids and tissues. J Pharm Biomed Anal. 2026;274:1\u201313.","journal-title":"J Pharm Biomed Anal"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-026-06485-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00216-026-06485-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-026-06485-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:58:09Z","timestamp":1780041489000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00216-026-06485-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["6485"],"URL":"https:\/\/doi.org\/10.1007\/s00216-026-06485-3","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All mouse plasma samples and mouse brain tissue samples were obtained from an internal pool of WT male and female animals prepared in accordance with the animal procedure nr 703_03 (according to EU directive 2010-63 and Belgian law in the Royal Decree of May 29, 2013) approved by the institutional ethical committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Source of biological material"}}]}}